FDA Inspection
Rostein, Daniel MD SCRostein, Daniel MD SC – FDA Inspection, Apr 19, 2016
Record Details
This FDA Inspection record concerns Rostein, Daniel MD SC, with an inspection on April 19, 2016, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Rostein, Daniel MD SC
- Inspection Date
- April 19, 2016
- Product Type
- Biologics
View Company Profile
ID · e55961af-e040-455a-a98e-bd632d8b9e42
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 968484
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
Other FDA inspections of Rostein, Daniel MD SC
4| Date | Classification | Office | Project area |
|---|---|---|---|
| July 14, 2025 | Not classified | Chicago District Office | |
| September 11, 2023 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| July 19, 2018 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| June 30, 2014 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Rostein, Daniel MD SC
- FDA Inspection 1275789 - 2025-07-14
- FDA Inspection 1217487 - 2023-09-11
- FDA Inspection 1061629 - 2018-07-19
- FDA Inspection 888990 - 2014-06-30
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.